South & Central America Medical Aesthetics Market is expected to reach US$ 814.57 million by 2028

Facial Aesthetic Products Segment to Dominate SCAM Medical Aesthetics Market during 2019–2028

According to a new market research study on “SCAM Medical Aesthetics Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product, Application, and End User,” is expected to reach US$ 814.57 million by 2028 from US$ 437.83 million in 2021. The market is estimated to grow at a CAGR of 9.3% from 2021 to 2028. The report provides trends prevailing in the SCAM medical aesthetics market along with the drivers and restraints pertaining to the market growth. Technological Advancements Associated with Medical Aesthetic Devices is the major factor driving the growth of the SCAM medical aesthetics market. However, clinical risks and complications associated with procedures may hinder the growth of SCAM medical aesthetics market.

The COVID-19 outbreak has severely impacted medical care in South and Central America. Also, the nations are famous for medical tourism, which is also affected by the pandemic. The second wave of the outbreak affected Brazil, Argentina, Uruguay, Chile, Peru, and Colombia. Among which Brazil recorded the majority of deaths. The region is expected to impose a second lockdown that will eventually hamper the region's healthcare industry. Market participants and end-users are losing their businesses due to the temporary closure of companies in different countries. In this situation, there was the discontinuation of physiotherapy and other related treatments. However, the COVID-19 outbreak has had a critical impact on the flow of medical care in the region. During the COVID-19 pandemic, South and Central America witnessed the shortage of hospital beds. Due to the pandemic, measures such as social distancing and self-quarantine were imposed. Both approaches to security have shown that a person's interest in aesthetics, in general, has changed. As the pandemic progresses, these variables can, in the long run, contradict each other in shaping the changing public interest in aesthetic procedures. Many aesthetic procedures, such as lipoplasty, breast implantation, and cosmetic dental treatments, have been negatively impacted due to the COVID-19 crisis. As the focus on COVID-19 patients became critical, Several clinics have postponed or dropped numerous elective surgeries, especially those that are considered non-urgent. The markets associated with aesthetic procedures, such as implants, injections, bariatric medical procedures, and similar products, are severely affected. The number of aesthetic procedures is expected to gain momentum once there is a fall in the number of COVID-19 cases. After the normal operation of aesthetic procedures has resumed, a mandatory COVID-19 test may be required in the future to receive any service. If patients need to be tested before the procedure, despite the diagnostic coronavirus test type, the location of sample collection and the logistics of safely and effectively sending samples to the laboratory are also important. Plastic surgery practices can either do smear tests on patients with the best tools possible or refer them to screening centers. Referring patients for preoperative screening tests requires coordination among the center, patient, and surgical plan. Additionally, most aesthetic surgery clients may be asymptomatic for COVID-19, and many walk-in centers may not conduct routine testing for asymptomatic patients. The referring doctor may then require a reference or request for an asymptomatic examination for the patient.

The market for medical aesthetics is segmented into product, application, end user, and country. Based on product market is segmented into facial aesthetic products, body contouring devices, cosmetic implants, skin aesthetic devices, hair removal devices, tattoo removal devices and others. In 2020, the facial aesthetic products segment held the largest share of the market, by product. Based on facial aesthetic products type market is segmented into dermal fillers, botulinum toxin, and microdermabrasion devices. Based on cosmetic implants type market is segmented into breast implants, facial implants, and others. Based on body contouring devices market is segmented into liposuction devices, nonsurgical fat reduction devices, and cellulite reduction devices. Based on skin aesthetic devices market is segmented into laser skin resurfacing devices, light therapy devices, nonsurgical skin tightening devices, and micro-needling products. Based on the application market was segmented into facial and body contouring, facial and skin rejuvenation, breast augmentation, hair removal, reconstructive surgery, tattoo removal and others. In 2020, the facial and body contouring segment held the largest share of the market, by application. Based on the end user market was segmented into hospitals, dermatology clinics, medical spas and beauty centers and home care. In 2020, the hospitals segment held the largest share of the market, by end user. Based on country, the market is segmented into the Brazil, Argentina, and RoSCAM. Brazil held the largest share of the market in 2020.

Allergan Plc, Alma Lasers, Galderma, Hologic, Inc., and Mentor Worldwide, LLC are among the leading companies in the SCAM medical aesthetics market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, Allergan Aesthetics announced that they had entered into a warrant agreement with Cypris Medical, a privately held, medical device company in Chicago. After completing a clinical trial in 2021, Allergan Aesthetics will have the right to exercise an option to acquire Cypris Medical, including the company's Xact device. The planned clinical trial will evaluate the safety and effectiveness of Xact in treating midface descent and neck lifts.